Search

everythinglearnresearchcommunity

for

Search:↓

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.

K16 can partially replace K14 but causes hair loss and skin issues.

Pitx2 helps outer root sheath cells differentiate but can't start hair growth on its own.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Shift nurses show altered body temperature and stress hormone levels, suggesting their body clocks adjust to irregular schedules.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Mice lacking Insig proteins had hair growth problems due to cholesterol buildup, but this was fixed by the drug simvastatin.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

GLI2 increases follistatin production in human skin cells.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

A new skin-whitening agent using a peptide from wheat is safe and effective at reducing skin pigmentation.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.